INDIVIOR PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 726.50 GBX | +1.18% |
|
-20.16% | -38.69% |
| 09-05 | Transcript : Indivior PLC Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM | |
| 09-04 | Indivior reports "disappointing" results for study with Aelis Farma | AN |
Evolution of the Average Target: Indivior PLC
Evolution of the Target Price: Indivior PLC
Changes in Analyst Recommendations: Indivior PLC
60d86.xKXtqmK88Qmjw9tH2GDY1HNKjCU70I7xD2jFHYlQvqw.nPC89RXzxD_Bro8R6lS0kRIC4393ueODeV2UdfAH1c3y8NrEVPOgOJeyng~e349abed8a19352306aee6c9609a5bde
More recommendations
| Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
|---|---|---|---|---|---|---|
| +149.59% | ||||||
| +9.50% | ||||||
| +4.23% | ||||||
| -15.19% | ||||||
| +8.72% | ||||||
| +24.75% | ||||||
| - | - | - | - | |||
| - | - | - | - | |||
| +26.29% | ||||||
| Average | +29.70% | |||||
| Weighted average by Cap. | +9.52% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
9.351USD
Average target price
23.34USD
Spread / Average Target
+149.59%
High Price Target
27.45USD
Spread / Highest target
+193.54%
Low Price Target
19.24USD
Spread / Lowest Target
+105.80%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Deutsche Bank Securities | |
| Craig-Hallum | |
| Liberum Capital | |
| Morgan Stanley |
Trading Rating
Investor Rating
ESG Refinitiv
B
- Stock Market
- Equities
- INDV Stock
- Consensus Indivior PLC
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition